Estradiol/testosterone topical gel - ANI Pharmaceuticals/Endo

Drug Profile

Estradiol/testosterone topical gel - ANI Pharmaceuticals/Endo

Alternative Names: LibiGel-E/T; Testosterone/estradiol topical gel - ANI Pharmaceuticals/Endo

Latest Information Update: 21 Aug 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Antares Pharma
  • Developer Endo International
  • Class Estradiol congeners; Estrenes; Hormonal replacements; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Estrogen receptor agonists; Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Female sexual dysfunction; Hot flashes

Most Recent Events

  • 21 Aug 2015 No recent reports of development identified - Phase-II for Female sexual dysfunction in Canada (Transdermal)
  • 21 Aug 2015 No recent reports of development identified - Phase-II for Hot flashes in Canada (Transdermal)
  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top